Equifax (EFX) Financials

Equifax’s available quarterly statements show a business with strong long-term revenue and earnings growth, but with more recent pressure on margins, cash balances and leverage. The data also includes several restated periods and unusual balance-sheet classifications, so investors should focus on broad trends rather than isolated figures.

• Revenue has expanded steadily. Total revenue increased from $1.24 billion in Q1 2023 to $1.64 billion in Q2 2026. Q2 2026 revenue rose approximately 10.5% from $1.48 billion in the restated Q2 2025 period, primarily reflecting growth in non-interest income.
• Longer-term earnings growth remains meaningful. Consolidated net income increased from $113.5 million in Q1 2023 to $185.1 million in Q2 2026. Diluted EPS also rose from $0.91 to $1.54 over the same comparison, helped by earnings growth and a declining share count.
• Share repurchases are supporting per-share results. Weighted average diluted shares declined from approximately 125.1 million in Q1 2025 to 119.2 million in Q2 2026. Equifax repurchased $300 million of common stock in Q2 2026 after repurchasing $260 million in Q1 and $500.1 million in Q4 2025.
• Operating cash flow remains robust. Q2 2026 operating cash flow was $339.8 million, nearly twice consolidated net income. Although down from $361.1 million in Q2 2025, the company has generated positive operating cash flow in every reported quarter in the supplied period.
• Dividend payments have increased. The quarterly dividend per share rose from $0.39 throughout 2023 and 2024 to $0.50 in Q4 2025 and $0.56 in Q1 and Q2 2026, indicating continued confidence in recurring cash generation.
• Investment activity is consistently consuming cash. Equifax purchased $135 million of investment securities in Q2 2026, compared with $120.4 million in Q1 and $204.1 million in Q4 2025. These outflows may represent balance-sheet management or investment deployment, but they reduce cash available for debt reduction and shareholder returns.
• Balance-sheet classifications require caution. Reported premises and equipment values are negative in several periods before turning positive at $1.93 billion in Q2 2026, while intangible assets also fall sharply from $4.37 billion in Q1 2026 to $1.32 billion in Q2. These movements appear affected by classification or restatement issues and should be reconciled with Equifax’s filings before drawing conclusions about asset quality.
• Q2 2026 profitability weakened year over year. Net income declined from $192.6 million in restated Q2 2025 to $185.1 million, while pretax income fell from $261.3 million to $256.9 million. Total non-interest expense increased to $1.386 billion, including $773.7 million of property and liability insurance claims.
• Margins are under pressure. Q2 2026 net income represented approximately 11.3% of revenue, down from about 13.0% in Q2 2025. Rising claims costs, depreciation and other operating expenses are offsetting some of the benefit from revenue growth.
• Leverage and liquidity are important risks. Short- and long-term debt totaled approximately $5.59 billion at June 30, 2026, up from $5.07 billion a year earlier, while cash declined to $170.1 million from $189.0 million. Q2 financing cash flow was negative $217.2 million despite $432.9 million of new debt issuance, reflecting $275.3 million of debt repayments, $300 million of buybacks and $72 million of dividends.

Overall, Equifax continues to demonstrate durable revenue generation, positive operating cash flow and strong capital returns. However, the latest quarter suggests that investors should closely monitor insurance-claim costs, operating margins, debt-funded shareholder distributions and the company’s relatively limited cash balance.